Lansforsakringar Fondforvaltning Ab (Publ) Sarepta Therapeutics, Inc. Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $15.9 Billion
- Q1 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 12,740 shares of SRPT stock, worth $811,028. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,740
Previous 17,885
28.77%
Holding current value
$811,028
Previous $2.17 Million
62.6%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
507Shares Held
88.9MCall Options Held
1.5MPut Options Held
1.05M-
Black Rock Inc. New York, NY10.3MShares$657 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$577 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$575 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$259 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$214 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.57B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...